INDEX 



945 



Multiple myeloma, and Bence-Jones 

 protein, metabolic study of Hopkins 

 and Savory, table, 492, 493. 



metabolic study of Seegelken, 



table, 495, 496. 



metabolic study of Walters, 

 tables, 496, 497, 498. 



myelopathic proteosuria (Kah- 

 ler's disease), 498. 



Muscle fiber, in feces, in pancreatic 

 disease, 664, 665. 



Muscle power, influence on, of glu- 

 cose, 715. 



Muscles, effect on, of anaphylaxis, 204. 



Muscular atrophy, progressive, metabo- 

 lism in, 730. 



secondary to chronic arthritis, blood 

 sugar in, 722. 



Muscular contraction, source of en- 

 ergy for, 709. 



glucose supply, 715. 



oxygen supply, 709. 



Muscular dystrophy, progressive, see 

 Progressive muscular dystrophy. 



Muscular system, physiology of, in 

 undernutrition, 17. 



Muscular weakness, due to inadequate 

 or non-utilizable food supply, 715. 



Myasthenia gravis, metabolism in, 730. 



Myelopathic proteosuria, 498. 



Necrosis, liver, experimental, urine in, 

 842. 



of the pancreas, acute toxic, "fat 

 necrosis," 684. 



toxic element in, 688. 



Nephritic toxicosis, 394. 



and edema of the brain, 394. 



possible cause of, cholin and neurin, 

 396. 



nephrolysins, 396. 



organic base, 396. 



: sodium chlorid, 395. 



trimethylamin, 395. 



summary of, 396. 



Nephritides, gastric disturbances in, 



and metabolism, 623. 

 Nephritis, acidosis in, 313. 



diagnosis of, 90. 



therapy for, 90. 



type and cause of, 89. 



amino acids in, 331. 



blood lipoids in, 341. 



carbohydrate metabolism in, blood 

 sugar, 343. 



utilization of carbohydrates, 343. 



chlorid threshold in, 363. 

 Atchley's observations, 365. 



Nephritis, chlorid threshold in, formu- 

 lae of Ambard and Weil, 364. 



McLean's observations, 365. 

 other investigations on, 366. 



cholesterol content of blood in, 342. 



clinical application in, 313. 



comparative value of uric acid, urea 

 and creatinin in blood in, 330. 



creatin in, 327. - 



creatinin In, 326. 



dyspnea in, 312. 



edema in, 312. 



Epstein's dietetic therapy of, 191. 



treatment of, 189. 



factors in, 311. 



degenerative changes, 311. 



inflammatory changes, 311. 



renal insufficiency, 311. 



fat metabolism, analyses of Bloor, 

 table, 341. 



blood lipoids, 341. 



cholesterol content of blood, 342. 



lipemia, 342. 



lipuria (chyluria), 340. 



utilization of fat in nephritis, 



340. 



high blood pressure in, 313. 



increased arterial pressure in, 397, 

 398. 



acute nephritis, 398. 

 cause of, 401. 



blood volume and plethora, 



402. 



epinephrin, 404. 



increased vasomotor tone, 403. 



insufficient renal function, 401. 



internal secretions derived 



from kidney, 405. 



viscosity of blood, 402. 



chronic diffuse (parenchymatous) 



nephritis, 399. 



essential hypertension and pri- 

 mary contracted kidney, 400. 



influence on, of food products, 



406. 



nephrosis, 398. 



occurrence of, 398. 



and secondary contracted kidney, 



399. 



lipemia in, 342. 



lipuria in, 340. 



metabolism in, amino acids, 331. 

 analysis of human muscle, nor- 

 mal and nephritis, 320. 



analysis of tissue in nephritis, 



321. 



carbohydrate, 343. 



chlorid threshold, 363. 



